These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 8790595

  • 1. Specific 125I neuropeptide Y binding to intact cultured bovine adrenal medulla capillary endothelial cells.
    Sanabria P, Silva WI.
    Microcirculation; 1994 Dec; 1(4):267-73. PubMed ID: 8790595
    [Abstract] [Full Text] [Related]

  • 2. BODIPY-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes.
    Dumont Y, Gaudreau P, Mazzuferi M, Langlois D, Chabot JG, Fournier A, Simonato M, Quirion R.
    Br J Pharmacol; 2005 Dec; 146(8):1069-81. PubMed ID: 16231000
    [Abstract] [Full Text] [Related]

  • 3. Binding sites for 125I-neuropeptide Y (NPY) on membranes from bovine adrenal medulla.
    Cherdchu C, Deupree JD, Hexum TD.
    Eur J Pharmacol; 1989 Dec 07; 173(2-3):115-9. PubMed ID: 2625132
    [Abstract] [Full Text] [Related]

  • 4. Identification of cultured cells selectively expressing Y1-, Y2-, or Y3-type receptors for neuropeptide Y/peptide YY.
    Wahlestedt C, Regunathan S, Reis DJ.
    Life Sci; 1992 Dec 07; 50(4):PL7-12. PubMed ID: 1310131
    [Abstract] [Full Text] [Related]

  • 5. Regional distribution of putative NPY Y1 receptors and neurons expressing Y1 mRNA in forebrain areas of the rat central nervous system.
    Larsen PJ, Sheikh SP, Jakobsen CR, Schwartz TW, Mikkelsen JD.
    Eur J Neurosci; 1993 Dec 01; 5(12):1622-37. PubMed ID: 8124516
    [Abstract] [Full Text] [Related]

  • 6. Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor.
    Gehlert DR, Schober DA, Beavers L, Gadski R, Hoffman JA, Smiley DL, Chance RE, Lundell I, Larhammar D.
    Mol Pharmacol; 1996 Jul 01; 50(1):112-8. PubMed ID: 8700103
    [Abstract] [Full Text] [Related]

  • 7. [Leu31-Pro34] neuropeptide Y identifies a subtype of 125I-labeled peptide YY binding sites in the rat brain.
    Gehlert DR, Gackenheimer SL, Schober DA.
    Neurochem Int; 1992 Jul 01; 21(1):45-67. PubMed ID: 1303142
    [Abstract] [Full Text] [Related]

  • 8. Expression of functional Y1 receptors for neuropeptide Y in human Ewing's sarcoma cell lines.
    van Valen F, Winkelmann W, Jürgens H.
    J Cancer Res Clin Oncol; 1992 Jul 01; 118(7):529-36. PubMed ID: 1320624
    [Abstract] [Full Text] [Related]

  • 9. Distribution of [Leu31,Pro34]NPY-sensitive, BIBP3226-insensitive [125I]PYY(3-36) binding sites in rat brain: possible relationship to Y5 NPY receptors.
    Widdowson PS, Buckingham R, Williams G.
    Brain Res; 1997 Dec 05; 778(1):242-50. PubMed ID: 9462897
    [Abstract] [Full Text] [Related]

  • 10. Functional characterization of receptors with affinity for PYY, NPY, [Leu31,Pro34]NPY and PP in a human colonic epithelial cell line.
    Cox HM, Tough IR.
    Br J Pharmacol; 1995 Nov 05; 116(6):2673-8. PubMed ID: 8590988
    [Abstract] [Full Text] [Related]

  • 11. Neuropeptide Y inhibits forskolin-stimulated adenylate cyclase in bovine adrenal chromaffin cells via a pertussis toxin-sensitive process.
    Zhu J, Li W, Toews ML, Hexum TD.
    J Pharmacol Exp Ther; 1992 Dec 05; 263(3):1479-86. PubMed ID: 1335068
    [Abstract] [Full Text] [Related]

  • 12. Neuropeptide Y binding and inhibition of cAMP accumulation in human neuroepithelioma cells.
    Lobaugh LA, Blackshear PJ.
    Am J Physiol; 1990 May 05; 258(5 Pt 1):C913-22. PubMed ID: 2159234
    [Abstract] [Full Text] [Related]

  • 13. Characterization of a Y1-preferring NPY/PYY receptor in HT-29 cells.
    Mannon PJ, Mervin SJ, Sheriff-Carter KD.
    Am J Physiol; 1994 Nov 05; 267(5 Pt 1):G901-7. PubMed ID: 7977753
    [Abstract] [Full Text] [Related]

  • 14. Identification and functional studies of a specific peptide YY-preferring receptor in dog adipocytes.
    Castan I, Valet P, Voisin T, Quideau N, Laburthe M, Lafontan M.
    Endocrinology; 1992 Oct 05; 131(4):1970-6. PubMed ID: 1327725
    [Abstract] [Full Text] [Related]

  • 15. Characterization of neuropeptide Y binding sites in rat brain membrane preparations using [125I][Leu31,Pro34]peptide YY and [125I]peptide YY3-36 as selective Y1 and Y2 radioligands.
    Dumont Y, Fournier A, St-Pierre S, Quirion R.
    J Pharmacol Exp Ther; 1995 Feb 05; 272(2):673-80. PubMed ID: 7853181
    [Abstract] [Full Text] [Related]

  • 16. Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type.
    Larhammar D, Blomqvist AG, Yee F, Jazin E, Yoo H, Wahlested C.
    J Biol Chem; 1992 Jun 05; 267(16):10935-8. PubMed ID: 1317848
    [Abstract] [Full Text] [Related]

  • 17. The neuropeptide Y Y1 antagonist, 1229U91, a potent agonist for the human pancreatic polypeptide-preferring (NPY Y4) receptor.
    Schober DA, Van Abbema AM, Smiley DL, Bruns RF, Gehlert DR.
    Peptides; 1998 Jun 05; 19(3):537-42. PubMed ID: 9533642
    [Abstract] [Full Text] [Related]

  • 18. Y2 receptors for peptide YY and neuropeptide Y on dispersed chief cells from guinea pig stomach.
    Singh G, Singh L, Raufman JP.
    Am J Physiol; 1992 Apr 05; 262(4 Pt 1):G756-62. PubMed ID: 1314499
    [Abstract] [Full Text] [Related]

  • 19. Neuropeptide Y suppresses the neurogenic inflammatory response in the rabbit eye; mode of action.
    Grundemar L, Wahlestedt C, Wang ZY.
    Regul Pept; 1993 Jan 22; 43(1-2):57-64. PubMed ID: 8381238
    [Abstract] [Full Text] [Related]

  • 20. Characterization of the receptors for peptide-YY and avian pancreatic polypeptide in chicken and pig brains.
    Inui A, Okita M, Miura M, Hirosue Y, Nakajima M, Inoue T, Oya M, Baba S.
    Endocrinology; 1990 Aug 22; 127(2):934-41. PubMed ID: 2164925
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.